Radiopharm Theranostics Says Its Proprietary Radiotracer Detected Brain Metastases in New Clinical Study; Shares Down 4%

MT NewswiresFeb 9 22:20 ET

Radiopharm Theranostics Raises $5 Million Via Private Placement to Lantheus, Shares Surge 58%

MT NewswiresJan 9 21:15 ET

ASX Biggest Gainers

MT NewswiresJan 9 20:45 ET

2 ASX Small-cap Shares Rocketing 35% to 54% Today

The Motley FoolJan 9 20:08 ET

Market Mover | Radiopharm Theranostics shares jump 45% on a A$8 million placement agreement

ReutersJan 9 18:49 ET

Radiopharm Approved to Start Lu-RAD202 Safety Trials, Door Open for In-human Studies

The Market HeraldDec 19, 2024 19:05 ET